Top Biotechnology companies in Europe by Revenue

This ranking features the top 260 Biotechnology companies in Europe ranked by Revenue, totaling a Revenue of USD 495.74 B, for June 24, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2 3 4 5 6

Frequently Asked Questions

Which Biotechnology company in Europe has the highest Revenue ?

The Biotechnology company in Europe with the highest Revenue is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 68.70 B.
Which Biotechnology company in Europe has the lowest Revenue ?

The Biotechnology company in Europe with the lowest Revenue is Advicenne S.A. (Paris Stock Exchange: ALDVI.PA) at None.

What are the top 10 Biotechnology companies in Europe by Revenue ?

The top 10 Biotechnology companies in Europe by Revenue are Roche Holding AG, AstraZeneca PLC, Novartis AG, Bayer AG, Sanofi, Novo Nordisk A/S, GSK plc, Siemens Healthineers AG, MERCK Kommanditgesellschaft auf Aktien and Sandoz Group AG.
What are the bottom 10 Biotechnology companies in Europe by Revenue ?

The bottom 10 Biotechnology companies in Europe by Revenue are Advicenne S.A., Atai Life Sciences N.V., Affluent Medical SA, Biosynex SA, genOway SA, Aptorum Group Limited, 2cureX AB (publ), Adocia SA, Akari Therapeutics, Plc and Cizzle Biotechnology Holdings Plc.